CORRESP Filing
IGC Pharma, Inc.
Date: Dec. 4, 2025 · CIK: 0001326205 · Accession: 0001185185-25-001921
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291567
Letter
Re: IGC Pharma, Inc. Registration Statement on Form S-3 (No. 333-291567)
December 4, 2025
VIA EDGAR
U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Attention: Jason Drory, Esq.
Division of Corporation Finance
Ladies and Gentlemen:
On behalf of IGC Pharma, Inc. (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 4:00 p.m., Eastern time, on Friday, December 5, 2025, or as soon as possible thereafter.
Please advise the undersigned of the effectiveness of the Registration Statement.
Very truly yours,
/s/ Kenneth Schlesinger
Kenneth Schlesinger
cc: Mr. Ram Mukunda Ms. Claudia Grimaldi
IGC Pharma, Inc. 10224 Falls Road Potomac, MD 20854
December 4, 2025
U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Attention: Jason Drory, Esq.
Division of Corporation Finance
Re: IGC Pharma, Inc. Registration Statement on Form S-3 (No. 333-291567)
Ladies and Gentlemen:
IGC Pharma, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:00 p.m., Eastern time, on Friday, December 5, 2025, or as soon as possible thereafter.
Very truly yours,
IGC PHARMA, INC.
Show Raw Text
CORRESP 1 filename1.htm December 4, 2025 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory, Esq. Division of Corporation Finance Re: IGC Pharma, Inc. Registration Statement on Form S-3 (No. 333-291567) Ladies and Gentlemen: On behalf of IGC Pharma, Inc. (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 4:00 p.m., Eastern time, on Friday, December 5, 2025, or as soon as possible thereafter. Please advise the undersigned of the effectiveness of the Registration Statement. Very truly yours, /s/ Kenneth Schlesinger Kenneth Schlesinger cc: Mr. Ram Mukunda Ms. Claudia Grimaldi IGC Pharma, Inc. 10224 Falls Road Potomac, MD 20854 December 4, 2025 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory, Esq. Division of Corporation Finance Re: IGC Pharma, Inc. Registration Statement on Form S-3 (No. 333-291567) Ladies and Gentlemen: IGC Pharma, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:00 p.m., Eastern time, on Friday, December 5, 2025, or as soon as possible thereafter. Very truly yours, IGC PHARMA, INC. By: /s/ Ram Mukunda Ram Mukunda Chief Executive Officer and President